granzyme b antibody
Granzyme B antibody |
|||
70R-11594 | Fitzgerald | 100 ug | 483.6 EUR |
Description: Rabbit polyclonal Granzyme B antibody |
|||
Granzyme B Antibody |
|||
48298-100ul | SAB | 100ul | 399.6 EUR |
Granzyme B Antibody |
|||
48298-50ul | SAB | 50ul | 286.8 EUR |
Granzyme B antibody |
|||
70R-14275 | Fitzgerald | 100 ug | 386.4 EUR |
Description: Affinity purified Rabbit polyclonal Granzyme B antibody |
|||
Granzyme B antibody |
|||
10R-G116b | Fitzgerald | 200 ug | 807.6 EUR |
Description: Mouse monoclonal Granzyme B antibody |
|||
Granzyme B antibody |
|||
10R-8010 | Fitzgerald | 100 ug | 564 EUR |
Description: Mouse monoclonal Granzyme B antibody |
|||
Granzyme B antibody |
|||
70R-31216 | Fitzgerald | 100 ug | 392.4 EUR |
Description: Rabbit polyclonal Granzyme B antibody |
|||
Granzyme B Antibody |
|||
ABF0175 | Lifescience Market | 100 ug | 525.6 EUR |
Granzyme B antibody |
|||
20R-1443 | Fitzgerald | 100 ug | 807.6 EUR |
Description: Rabbit polyclonal Granzyme B antibody |
|||
Granzyme B Antibody |
|||
3073R-100 | Biovision | each | 379.2 EUR |
Granzyme B Antibody |
|||
3073R-30T | Biovision | each | 175.2 EUR |
Granzyme B Antibody |
|||
33394-100ul | SAB | 100ul | 302.4 EUR |
Granzyme B Antibody |
|||
33394-50ul | SAB | 50ul | 224.4 EUR |
Granzyme B Antibody |
|||
DF7012 | Affbiotech | 200ul | 420 EUR |
Granzyme B Antibody |
|||
RQ4165 | NSJ Bioreagents | 100 ug | 356.15 EUR |
Description: Granzyme B is a serine protease that in humans is encoded by the GZMB gene. Granzyme B is expressed by cytotoxic T lymphocytes (CTL) and natural killer (NK) cells. CTL and NK cells share the remarkable ability to recognize specific infected target cells. They are thought to protect their host by inducing apoptosis of cells that bear on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein encoded by this gene is crucial for the rapid induction of target cell apoptosis by CTL in cell-mediated immune response. |
|||
Granzyme B Antibody |
|||
RQ5315 | NSJ Bioreagents | 100ul | 356.15 EUR |
Description: This enzyme is necessary for target cell lysis in cell-mediated immune responses. It cleaves after Asp. Seems to be linked to an activation cascade of caspases (aspartate-specific cysteine proteases) responsible for apoptosis execution. Cleaves caspase-3, -7, -9 and 10 to give rise to active enzymes mediating apoptosis. |
|||
Granzyme B Antibody |
|||
R30828 | NSJ Bioreagents | 100 ug | 356.15 EUR |
Description: Granzyme B is a serine protease that in humans is encoded by the GZMB gene. Granzyme B is expressed by cytotoxic T lymphocytes (CTL) and natural killer(NK) cells. CTL and NK cells share the remarkable ability to recognize specific infected target cells. They are though to protect their host by inducing apoptosis of cells that bear on their surface nonself antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein encoded by this gene is crucial for the rapid induction of target cell apoptosis by CTL in cell-mediated immune response. |
|||
Granzyme B Antibody |
|||
V9342-100UG | NSJ Bioreagents | 100ug | 349.3 EUR |
Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface antigens, usually peptides or proteins resulting from infection by intracellular pathogens. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTLs in the cell-mediated immune response. Granzyme B is useful as a marker in the identification of NK/T-cell lymphomas. High percentages of cytotoxic T-cells have been shown to be an unfavorable prognostic indicator in Hodgkin s Disease. |
|||
Granzyme B Antibody |
|||
V9342-20UG | NSJ Bioreagents | 20ug | 153.3 EUR |
Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface antigens, usually peptides or proteins resulting from infection by intracellular pathogens. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTLs in the cell-mediated immune response. Granzyme B is useful as a marker in the identification of NK/T-cell lymphomas. High percentages of cytotoxic T-cells have been shown to be an unfavorable prognostic indicator in Hodgkin s Disease. |
|||
Granzyme B Antibody |
|||
V9342SAF-100UG | NSJ Bioreagents | 100ug | 349.3 EUR |
Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface antigens, usually peptides or proteins resulting from infection by intracellular pathogens. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTLs in the cell-mediated immune response. Granzyme B is useful as a marker in the identification of NK/T-cell lymphomas. High percentages of cytotoxic T-cells have been shown to be an unfavorable prognostic indicator in Hodgkin s Disease. |
|||
Granzyme B Antibody |
|||
V9404-100UG | NSJ Bioreagents | 100ug | 349.3 EUR |
Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface antigens, usually peptides or proteins resulting from infection by intracellular pathogens. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTLs in the cell-mediated immune response. Granzyme B is useful as a marker in the identification of NK/T-cell lymphomas. High percentages of cytotoxic T-cells have been shown to be an unfavorable prognostic indicator in Hodgkin s Disease. |
|||
Granzyme B Antibody |
|||
V9404-20UG | NSJ Bioreagents | 20ug | 153.3 EUR |
Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface antigens, usually peptides or proteins resulting from infection by intracellular pathogens. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTLs in the cell-mediated immune response. Granzyme B is useful as a marker in the identification of NK/T-cell lymphomas. High percentages of cytotoxic T-cells have been shown to be an unfavorable prognostic indicator in Hodgkin s Disease. |
|||
Granzyme B Antibody |
|||
V9404SAF-100UG | NSJ Bioreagents | 100ug | 349.3 EUR |
Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface antigens, usually peptides or proteins resulting from infection by intracellular pathogens. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTLs in the cell-mediated immune response. Granzyme B is useful as a marker in the identification of NK/T-cell lymphomas. High percentages of cytotoxic T-cells have been shown to be an unfavorable prognostic indicator in Hodgkin s Disease. |
|||
Granzyme B Antibody |
|||
V2564-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'non-self' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTLs in the cell-mediated immune response. Granzyme B is useful as a marker in the identification of NK/T-cell lymphomas. High percentages of cytotoxic T-cells have been shown to be an unfavorable prognostic indicator in Hodgkin's Disease. |
|||
Granzyme B Antibody |
|||
V2564-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'non-self' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTLs in the cell-mediated immune response. Granzyme B is useful as a marker in the identification of NK/T-cell lymphomas. High percentages of cytotoxic T-cells have been shown to be an unfavorable prognostic indicator in Hodgkin's Disease. |
|||
Granzyme B Antibody |
|||
V2564SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'non-self' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTLs in the cell-mediated immune response. Granzyme B is useful as a marker in the identification of NK/T-cell lymphomas. High percentages of cytotoxic T-cells have been shown to be an unfavorable prognostic indicator in Hodgkin's Disease. |
|||
Granzyme B Antibody |
|||
V7638-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: This enzyme is necessary for target cell lysis in cell-mediated immune responses. It cleaves after Asp. Seems to be linked to an activation cascade of caspases (aspartate-specific cysteine proteases) responsible for apoptosis execution. Cleaves caspase-3, -7, -9 and 10 to give rise to active enzymes mediating apoptosis. [UniProt] |
|||
Granzyme B Antibody |
|||
V7638-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: This enzyme is necessary for target cell lysis in cell-mediated immune responses. It cleaves after Asp. Seems to be linked to an activation cascade of caspases (aspartate-specific cysteine proteases) responsible for apoptosis execution. Cleaves caspase-3, -7, -9 and 10 to give rise to active enzymes mediating apoptosis. [UniProt] |
|||
Granzyme B Antibody |
|||
V7638SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: This enzyme is necessary for target cell lysis in cell-mediated immune responses. It cleaves after Asp. Seems to be linked to an activation cascade of caspases (aspartate-specific cysteine proteases) responsible for apoptosis execution. Cleaves caspase-3, -7, -9 and 10 to give rise to active enzymes mediating apoptosis. [UniProt] |
|||
Granzyme B Antibody |
|||
V7834-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTLs in the cell-mediated immune response. Granzyme B is useful as a marker in the identification of NK/T-cell lymphomas. High percentages of cytotoxic T-cells have been shown to be an unfavorable prognostic indicator in Hodgkin's Disease. |
|||
Granzyme B Antibody |
|||
V7834-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTLs in the cell-mediated immune response. Granzyme B is useful as a marker in the identification of NK/T-cell lymphomas. High percentages of cytotoxic T-cells have been shown to be an unfavorable prognostic indicator in Hodgkin's Disease. |
|||
Granzyme B Antibody |
|||
V7834SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTLs in the cell-mediated immune response. Granzyme B is useful as a marker in the identification of NK/T-cell lymphomas. High percentages of cytotoxic T-cells have been shown to be an unfavorable prognostic indicator in Hodgkin's Disease. |
|||
Granzyme B Antibody |
|||
V7835-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTLs in the cell-mediated immune response. Granzyme B is useful as a marker in the identification of NK/T-cell lymphomas. High percentages of cytotoxic T-cells have been shown to be an unfavorable prognostic indicator in Hodgkin's Disease. |
|||
Granzyme B Antibody |
|||
V7835-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTLs in the cell-mediated immune response. Granzyme B is useful as a marker in the identification of NK/T-cell lymphomas. High percentages of cytotoxic T-cells have been shown to be an unfavorable prognostic indicator in Hodgkin's Disease. |
|||
Granzyme B Antibody |
|||
V7835SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTLs in the cell-mediated immune response. Granzyme B is useful as a marker in the identification of NK/T-cell lymphomas. High percentages of cytotoxic T-cells have been shown to be an unfavorable prognostic indicator in Hodgkin's Disease. |
|||
Granzyme B Antibody |
|||
V8027-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTLs in the cell-mediated immune response. Granzyme B is useful as a marker in the identification of NK/T-cell lymphomas. High percentages of cytotoxic T-cells have been shown to be an unfavorable prognostic indicator in Hodgkin's Disease. |
|||
Granzyme B Antibody |
|||
V8027-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTLs in the cell-mediated immune response. Granzyme B is useful as a marker in the identification of NK/T-cell lymphomas. High percentages of cytotoxic T-cells have been shown to be an unfavorable prognostic indicator in Hodgkin's Disease. |
|||
Granzyme B Antibody |
|||
V8027BTN | NSJ Bioreagents | 500 ul | 349.3 EUR |
Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface s Disease. |
|||
Granzyme B Antibody |
|||
V8027SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTLs in the cell-mediated immune response. Granzyme B is useful as a marker in the identification of NK/T-cell lymphomas. High percentages of cytotoxic T-cells have been shown to be an unfavorable prognostic indicator in Hodgkin's Disease. |
|||
Granzyme B Antibody |
|||
V3845-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'non-self' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTLs in the cell-mediated immune response. Granzyme B is useful as a marker in the identification of NK/T-cell lymphomas. High percentages of cytotoxic T-cells have been shown to be an unfavorable prognostic indicator in Hodgkin's Disease. |
|||
Granzyme B Antibody |
|||
V3845-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'non-self' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTLs in the cell-mediated immune response. Granzyme B is useful as a marker in the identification of NK/T-cell lymphomas. High percentages of cytotoxic T-cells have been shown to be an unfavorable prognostic indicator in Hodgkin's Disease. |
|||
Granzyme B Antibody |
|||
V3845SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Granzyme B is a member of the granule serine protease family stored specifically in NK cells or cytotoxic T cells. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'non-self' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. Granzyme B is crucial for the rapid induction of target cell apoptosis by CTLs in the cell-mediated immune response. Granzyme B is useful as a marker in the identification of NK/T-cell lymphomas. High percentages of cytotoxic T-cells have been shown to be an unfavorable prognostic indicator in Hodgkin's Disease. |
|||
Granzyme B Antibody |
|||
R20456-0.1ML | NSJ Bioreagents | 100ul | 409 EUR |
Granzyme B antibody (PE) |
|||
61R-G116cPE | Fitzgerald | 100 ug | 340.8 EUR |
Description: Mouse monoclonal Granzyme B antibody (PE) |
|||
Granzyme B/H antibody |
|||
70R-49841 | Fitzgerald | 100 ul | 292.8 EUR |
Description: Purified Polyclonal Granzyme B/H antibody |
|||
Granzyme B/H Antibody |
|||
AF0175 | Affbiotech | 200ul | 420 EUR |
Granzyme B / H Antibody |
|||
20-abx009176 | Abbexa |
|
|
Granzyme B antibody (biotin) |
|||
61R-1664 | Fitzgerald | 50 ug | 424.8 EUR |
Description: Rat monoclonal Granzyme B antibody (biotin) |
|||
Polyclonal Granzyme B Antibody |
|||
APR05431G | Leading Biology | 0.1ml | 580.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Granzyme B . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal Granzyme B Antibody |
|||
APR00019G | Leading Biology | 0.1mg | 580.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Granzyme B . This antibody is tested and proven to work in the following applications: |
|||
Granzyme B Antibody (Clone B18.1) |
|||
3073-100 | Biovision | each | 444 EUR |
Granzyme B (GZMB) Antibody |
|||
abx233737-100ug | Abbexa | 100 ug | 661.2 EUR |
Granzyme B (GZMB) Antibody |
|||
20-abx225208 | Abbexa |
|
|
Granzyme B (GZMB) Antibody |
|||
20-abx109837 | Abbexa |
|
|
Granzyme B (GZMB) Antibody |
|||
20-abx100561 | Abbexa |
|
|
Granzyme B (GZMB) Antibody |
|||
20-abx172667 | Abbexa |
|
|
Granzyme B (GZMB) Antibody |
|||
20-abx172668 | Abbexa |
|
|
Granzyme B (GZMB) Antibody |
|||
20-abx013099 | Abbexa |
|
|
Granzyme B (GZMB) Antibody |
|||
20-abx001994 | Abbexa |
|
|
Granzyme B (GZMB) Antibody |
|||
20-abx112844 | Abbexa |
|
|